Abstract:The bottom-up self-assembly of protein subunits into supramolecular nanoarchitectures is ubiquitously exploited to recapitulate and expand the features of natural proteins to advance nanoscience in medicine. Various chemical and biological re-engineering approaches are available to render diverse functions in the given proteins. They are, unfortunately, capable of compromising protein integrity and stability after extensive modifications. In this study, we introduce a new protein re-engineering method, metal ion assisted interface re-engineering (MAIR), to serve as a robust and universal strategy to extend the functions of self-assembly proteins by boosting structural features to advance their diverse biomedical applications. In particular, the MAIR strategy was applied to a widely used natural protein, ferritin, as a model protein to coordinate with copper ions in its mutagenic artificial metal binding domain. Structure directed rational protein mutagenesis was carried out at the C2 interface amino acid residues of the ferritin subunit for metal ion coordination site optimization. Copper binding at the artificial binding pocket was highly specific over the other divalent ions present in physiological fluids, and the structurally embedded copper ion in turn strengthened the overall protein integrity and stability. In the presence of isotopic copper-64, the interface re-engineered ferritin worked as a chelator-free molecular nanoprobe with an extraordinarily high specific activity to allow PET imaging of tumors in live animals. We also found that the re-engineered ferritin coordinating with copper ions demonstrates high drug loading capacity of a widely used anti-cancer agent, doxorubicin (DOX), to achieve significant drug retention at the tumor site and enhance tumor regression for improved anti-cancer effects. The MAIR approach, thus, exploited the copper ion to facilitate efficient one-step labeling of mutant ferritin derivatives for simultaneous molecular imaging and drug delivery. The reported interface re-engineering strategy provides an unparalleled opportunity to expand protein biofunctions to serve as a new theranostic agent in cancer research.

Cytomembrane‐Mediated Transport of Metal Ions with Biological Specificity

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents

Biomembrane and metal nanostructures for cancer theranostics: The state of the art in the combination of organic and inorganic chemistry

Exogeneous Metal Ions As Therapeutic Agents in Cardiovascular Disease and Their Delivery Strategies.

A Facile and Universal Method for Preparing Polyethylene Glycol-Metal Hybrid Nanoparticles and Their Application in Tumor Theranostics

Metal-Organic Frameworks As Intelligent Drug Nanocarriers for Cancer Therapy.

Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy

Organelle-targeting Metal Complexes: from Molecular Design to Bio-Applications

Biomolecule conjugated metal nanoclusters: bio-inspiration strategies, targeted therapeutics, and diagnostics.

Metal ion interference therapy: metal-based nanomaterial-mediated mechanisms and strategies to boost intracellular "ion overload" for cancer treatment.

A tumor-sensitive biological metal-organic complex for drug delivery and cancer therapy

Synergistic integration of metal nanoclusters and biomolecules as hybrid systems for therapeutic applications

A Universal Approach to Render Nanomedicine with Biological Identity Derived from Cell Membranes.

Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics

A Brief Review on Manipulation of Essential Metal Ions as Nanomedicine for Cancer Therapy

Metal Ion-Based Supramolecular Self-Assembly for Cancer Theranostics

New anti-cancer explorations based on metal ions

Metal ion assisted interface re-engineering of a ferritin nanocage for enhanced biofunctions and cancer therapy.

Coupling Photoresponsive Transmembrane Ion Transport with Transition Metal Catalysis

Functionalization of Metal Nanoclusters for Biomedical Applications